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• With the growing opioid epidemic in 
the United States, there has been an 
increase in the number of opioid 
exposed newborns.  For example, 
Yale New Haven Children’s Hospital 
saw a 74% increase in infants 
exposed to methadone in utero 
between 2003 – 2009 (Grossman et 
al, 2018).
• Purpose:  To combat these rising 
numbers, Lehigh Valley Health 
Network should use the most effective 
treatment tool for Neonatal Abstinence 
Syndrome (NAS) supported by up-to-
date research.
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For infants at risk for NAS on the 
Mother Baby Unit, will implementation 
of Eating, Sleeping, and Consoling 
(ESC) Care Tool as compared to the 
current Neonatal Abstinence 
Guidelines from Birth to Discharge 
Pathway decrease the use of 
pharmacological agents?
LVHN will carry out the 
standardization of care for infants 
suffering from NAS, as decided on by 
the state of Pennsylvania
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PHARMACOLOGICAL VS. NON-PHARMACOLOGICAL TREATMENT OF INFANTS WITH NEONATAL ABSTINENCE 
SYNDROME   
Infants in the Pre-Intervention Period Infants in the Post-Intervention Period
Due to the state of Pennsylvania 
currently working toward the 
standardization of care for infants 
experiencing NAS, there was no 
implementation of the ESC Care Tool at 
LVHN.  In place of implementation, 
research on other hospitals’ 
implementation process was conducted 
and reported on.
• Less than 10-40% of infants with prenatal long-
acting opioid exposure require pharmacologic 
treatment using the ESC assessment and non-
pharm care method. In contrast, most studies 
report initiating pharmacologic therapy for NAS 
at a rate of 50-80% when using a numerical, 
score based-approach (Wachman et al., 2017).
• Grossman et al demonstrated “supportive, non-
pharmacologic interventions combined with 
assessments that focused on the functional well-
being of infants with NAS,” such as the ESC 
tool, “reduced resource use, including less use 
of morphine and fewer NICU stays” (8).  
• Per Grossman et al, “using the ESC approach 
exposed significantly fewer infants to 
pharmacologic treatment than if we used the 
Finnegan Neonatal Abstinence Scoring System 
approach” (4).
Data from Yale New Haven Children’s Hospital
